Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 No DAC Vial Size Comparison

2mg 2mL bacteriostatic water 1,000mcg/mL 4–7 days at 100mcg 3×/day Higher per-mg cost Best for short pilot studies or dose-finding phases—minimizes waste but requires frequent reconstitution 5mg 5mL bacteriostatic water 12–18 days at 100mcg 3×/day Moderate per

This comparison does not assign a generated winner or score.

  • 2mg
  • 2mL bacteriostatic water
  • 1,000mcg/mL
  • 4–7 days at 100mcg 3×/day
  • Higher per-mg cost
  • Best for short pilot studies or dose-finding phases—minimizes waste but requires frequent reconstitution
  • 5mg
  • 5mL bacteriostatic water
  • 12–18 days at 100mcg 3×/day
  • Moderate per-mg cost
  • Optimal balance for most 8–12 week research protocols—depletes within stability window without excessive handling
  • 10mg
  • 10mL bacteriostatic water
  • 24–33 days at 100mcg 3×/day
  • Lowest per-mg cost
  • Cost-effective only if your protocol genuinely uses 300–400mcg daily—otherwise you pay for peptide that degrades before use
  • The bottom line: vial size is a consumption-rate decision, not a potency decision. The peptide molecule is identical across all vial sizes—what changes is how much you'll waste if your depletion rate doesn't match the 28-day stability ceiling.
More references

Related material